Dual-Pathway Inhibition
Synergistically combines Levocetirizine to block histamine-induced symptoms (sneezing/itching) and Montelukast to inhibit leukotrienes that cause airway swelling and mucus production. (Ciebiada et al., 2008)
Loading...
Loading...
Levocetrizine 5 mg + Montelukast Sodium 10 mg
A premium dual-action respiratory formula designed to provide comprehensive relief from allergic rhinitis and comorbid asthma. Hiskast targets two distinct inflammatory pathways to clear nasal passages, reduce bronchial inflammation, and prevent allergic triggers from disrupting daily life.
A premium dual-action respiratory formula designed to provide comprehensive relief from allergic rhinitis and comorbid asthma. Hiskast targets two distinct inflammatory pathways to clear nasal passages, reduce bronchial inflammation, and prevent allergic triggers from disrupting daily life.
Synergistically combines Levocetirizine to block histamine-induced symptoms (sneezing/itching) and Montelukast to inhibit leukotrienes that cause airway swelling and mucus production. (Ciebiada et al., 2008)
Levocetirizine, the active R-enantiomer of Cetirizine, offers a higher affinity for H1 receptors, providing rapid relief from runny nose and watery eyes with a reduced risk of sedation. (Tillement, 2002)
Montelukast effectively blocks CysLT1 receptors in the lungs and nose, preventing the bronchoconstriction and inflammation typically triggered by allerge...
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
